Business Context and Reporting Period
Company: AMN Healthcare Services, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2010
Overview: AMN Healthcare is the nation's largest provider of comprehensive healthcare staffing and workforce solutions. The reporting period is significantly impacted by the acquisition of NF Investors, Inc. (NFI/Medfinders) on September 1, 2010, which added a home healthcare services segment and expanded managed services capabilities. The financial statements include NFI results only from the acquisition date forward.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2010 | Nine Months Ended Sep 30, 2010 |
|---|---|---|
| Revenue | $176.3 million | $468.9 million |
| Gross Profit | $48.3 million (27.4% margin) | $129.5 million (27.6% margin) |
| Net Loss | $(51.3) million | $(50.4) million |
| Net Loss Per Share (Basic/Diluted) | $(1.48) | $(1.52) |
| Cash and Cash Equivalents | $2.1 million | (Balance Sheet: $2.1 million) |
| Restricted Cash | $21.0 million | (Balance Sheet: $21.0 million) |
| Total Debt (Notes Payable) | $216.6 million (net of discount) | (Balance Sheet: $216.6 million) |
| Operating Cash Flow | N/A | $3.2 million |
Material Changes vs. Prior Period
- Revenue: Increased 6% year-over-year for the quarter ($176.3M vs. $166.4M) due to the NFI acquisition, though it decreased 24% for the nine-month period ($468.9M vs. $615.1M) driven by a reduction in the average number of temporary healthcare professionals on assignment.
- Profitability: Net loss widened significantly in the quarter to $51.3 million from $2.0 million in the prior year quarter. For the nine months, the net loss improved to $50.4 million from $119.5 million in the prior year, primarily due to a massive impairment charge in 2009.
- Impairment Charges: The company recorded $49.8 million in impairment and restructuring charges for both the three and nine months ended September 30, 2010. This includes a $40.9 million goodwill impairment and $8.9 million in indefinite-lived intangible asset impairments triggered by a decline in market capitalization below book value.
- Debt Structure: Total term loans increased from $105.6 million (Dec 31, 2009) to $216.6 million (Sep 30, 2010) following the refinancing of NFI debt and an amendment to the First Lien Credit Agreement.
- Liquidity: Cash and cash equivalents dropped from $27.1 million to $2.1 million, largely due to the cash used in the NFI acquisition and debt refinancing activities.
Guidance, Outlook, and Risks
- Acquisition Integration: Management anticipates that the NFI acquisition will improve the ability to deliver total workforce management solutions and achieve sales and operating efficiencies. The purchase price allocation is preliminary and subject to adjustment.
- Market Conditions: Demand remains below pre-2009 levels due to economic constraints on hospital budgets. Clients are increasingly relying on permanent staff and preferred vendor relationships. The home healthcare segment faces regulatory risks regarding Medicare/Medicaid reimbursement rates.
- Capital Structure Risks: The company issued 5,660 shares of Series A Conditional Convertible Preferred Stock as part of the NFI purchase price. These accrue dividends at 11% per annum until stockholder approval of conversion provisions. Failure to obtain approval could adversely affect capital raising and integration.
- Impairment Uncertainty: The goodwill impairment charge of $40.9 million is an estimate based on the first step of the impairment test. Finalization of the second step (implied fair value) is pending, and further adjustments may be required.
- Forward-Looking Statements: The company cautions that actual results may differ due to economic downturns, supply constraints for healthcare professionals, and the impact of the Affordable Care Act.
Investor Verification Checklist
- Impairment Finalization: Verify the final outcome of the second step of the goodwill impairment test, as the current $40.9 million charge is an estimate.
- Preferred Stock Conversion: Monitor the status of the stockholder vote required to convert the Series A Preferred Stock and forgive the 11% accrued dividends.
- Debt Covenants: Confirm continued compliance with the new financial covenants (Minimum Liquidity, Consolidated Leverage Ratio) under the amended First Lien and new Second Lien Credit Agreements.
- Working Capital Trends: Review Days Sales Outstanding (DSO), which increased to 67 days (54 days excluding NFI impact), to assess collection efficiency post-acquisition.
- Segment Performance: Analyze the standalone performance of the new Home Healthcare Services segment and the integration of NFI's managed services into existing operations.